Annual Report

Overview

The report records 2025 consolidated revenue of RMB125,662 thousand and describes commercialization progress for zevorcabtagene autoleucel. Its ESG section covers the Group and reports 362 employees and total GHG emissions of 8,711.42 tons of CO 2 equivalent. It also establishes a CT053 production-process GHG intensity target of at least 3% reduction in 2026 versus 2025.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services